查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386356

脑膜炎双球菌疫苗市场报告：2030 年趋势、预测与竞争分析

Meningococcal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

脑膜炎双球菌疫苗趋势与预测

2030年，全球脑膜炎双球菌疫苗市场预计将达到66.6亿美元，2024年至2030年的复合年增长率为8.5%。该市场的主要驱动因素是脑膜炎盛行率的增加、免疫计划的扩大以及新疫苗的持续开发。全球脑膜炎球菌疫苗市场的未来看起来充满希望，零售药局和医院药局市场充满机会。

脑膜炎双球菌疫苗市场洞察

Lucintel 预计结合疫苗将在预测期内实现最高增长，因为其具有比多醣疫苗更高的免疫抗原性和更低的反应原性等特征。

医院药房仍然是该市场中最大的部分，因为许多疫苗接种都是在医院进行的。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 未来哪个细分市场成长较快？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球脑膜炎双球菌疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球脑膜炎双球菌疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 全球脑膜炎双球菌疫苗市场（按类型）
    • 多醣
    • 结合疫苗
    • 联合疫苗
    • 男性B疫苗
    • 其他的
  • 全球脑膜炎双球菌疫苗市场（依最终用途）
    • 零售药房
    • 医院药房
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球脑膜炎双球菌疫苗市场区域分布
  • 北美脑膜炎球菌疫苗市场
  • 欧洲脑膜炎双球菌疫苗市场
  • 亚太脑膜炎双球菌疫苗市场
  • 其他区域性脑膜炎双球菌疫苗市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球脑膜炎双球菌疫苗市场成长机会
    • 全球脑膜炎双球菌疫苗市场成长机会（依最终用途）
    • 全球脑膜炎双球菌疫苗市场成长机会（按地区）
  • 全球脑膜炎双球菌疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球脑膜炎双球菌疫苗市场产能
    • 全球脑膜炎双球菌疫苗市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Merck
  • Baxter International
  • JN International Medical
  • Biomed
  • Pfizer
  • Glaxosmithkline
  • Serum Institute India
简介目录

Meningococcal Vaccine Trends and Forecast

The future of the global meningococcal vaccine market looks promising with opportunities in the retail pharmacy and hospital pharmacy markets. The global meningococcal vaccine market is expected to reach an estimated $6.66 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are growing prevalence of meningitis, expansion of immunization programs, and rising development of new vaccines.

A more than 150-page report is developed to help in your business decisions.

Meningococcal Vaccine by Segment

The study includes a forecast for the global meningococcal vaccine by type, end use, and region.

Meningococcal Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Polysaccharide
  • Conjugate Vaccines
  • Combination Vaccines
  • Men B Vaccines
  • Others

Meningococcal Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

Meningococcal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Meningococcal Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies meningococcal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the meningococcal vaccine companies profiled in this report include-

  • Merck
  • Baxter International
  • JN International Medical
  • Biomed
  • Pfizer
  • GlaxoSmithKline
  • Serum Institute India

Meningococcal Vaccine Market Insights

Lucintel forecasts that conjugate vaccine is expected to witness highest growth over the forecast period due to its features like more immunogenic and less reactogenic than polysaccharide vaccines.

Within this market, hospital pharmacy will remain the largest segment due to the high volume of vaccinations administered in this facility.

Features of the Global Meningococcal Vaccine Market

Market Size Estimates: Meningococcal vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Meningococcal vaccine market size by type, end use, and region in terms of value ($B).

Regional Analysis: Meningococcal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the meningococcal vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the meningococcal vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the meningococcal vaccine market size?

Answer: The global meningococcal vaccine market is expected to reach an estimated 6.66 billion by 2030.

Q.2 What is the growth forecast for meningococcal vaccine market?

Answer: The global meningococcal vaccine market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the meningococcal vaccine market?

Answer: The major drivers for this market are growing prevalence of meningitis, expansion of immunization programs, and rising development of new vaccines.

Q4. What are the major segments for meningococcal vaccine market?

Answer: The future of the meningococcal vaccine market looks promising with opportunities in the retail pharmacy and hospital pharmacy markets.

Q5. Who are the key meningococcal vaccine market companies?

Answer: Some of the key meningococcal vaccine companies are as follows:

  • Merck
  • Baxter International
  • JN International Medical
  • Biomed
  • Pfizer
  • GlaxoSmithKline
  • Serum Institute India

Q6. Which meningococcal vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that conjugate vaccine is expected to witness highest growth over the forecast period due to its features like more immunogenic and less reactogenic than polysaccharide vaccines.

Q7. In meningococcal vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of meningococcal disease among adolescents and young adults in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the meningococcal vaccine market by type (polysaccharide, conjugate vaccines, combination vaccines, men B vaccines, and others), end use (retail pharmacies, hospital pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Meningococcal Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Meningococcal Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Meningococcal Vaccine Market by Type
    • 3.3.1: Polysaccharide
    • 3.3.2: Conjugate Vaccines
    • 3.3.3: Combination Vaccines
    • 3.3.4: Men B Vaccines
    • 3.3.5: Others
  • 3.4: Global Meningococcal Vaccine Market by End Use
    • 3.4.1: Retail Pharmacies
    • 3.4.2: Hospital Pharmacies
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Meningococcal Vaccine Market by Region
  • 4.2: North American Meningococcal Vaccine Market
    • 4.2.2: North American Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others
  • 4.3: European Meningococcal Vaccine Market
    • 4.3.1: European Meningococcal Vaccine Market by Type: Polysaccharide, Conjugate Vaccines, Combination Vaccines, Men B Vaccines, and Others
    • 4.3.2: European Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others
  • 4.4: APAC Meningococcal Vaccine Market
    • 4.4.1: APAC Meningococcal Vaccine Market by Type: Polysaccharide, Conjugate Vaccines, Combination Vaccines, Men B Vaccines, and Others
    • 4.4.2: APAC Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others
  • 4.5: ROW Meningococcal Vaccine Market
    • 4.5.1: ROW Meningococcal Vaccine Market by Type: Polysaccharide, Conjugate Vaccines, Combination Vaccines, Men B Vaccines, and Others
    • 4.5.2: ROW Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Meningococcal Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Meningococcal Vaccine Market by End Use
    • 6.1.3: Growth Opportunities for the Global Meningococcal Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Meningococcal Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Meningococcal Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Meningococcal Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: Baxter International
  • 7.3: JN International Medical
  • 7.4: Biomed
  • 7.5: Pfizer
  • 7.6: Glaxosmithkline
  • 7.7: Serum Institute India